Today we’re delighted to publish the second case study into the use of Analyse-it.
The case study features a national clinical laboratory in the USA that offers more than 2,000 tests and combinations to major commercial and government laboratories. They use Analyse-it to determine analytical performance of automated immunoassays for some of the industry’s leading in-vitro diagnostic device makers -- including Abbott Diagnostics, Bayer Diagnostics, Beckman Coulter and Roche Diagnostics.
Unfortunately we cannot name the end-user, or the organisation she works for, in the case study. Although she was delighted to feature in the case study, at final approval her organisation's committee preferred the names be withheld. Thankfully they have allowed us to use the case study, albeit anonymously.
You can read the case study online now or download the Adobe PDF version.
We would love to feature more customer stories in case studies. If you can get approval to participate – which we realise is very difficult in many industries – and have 20 minutes to spare for a telephone interview, please contact us at firstname.lastname@example.org.
Today we’re delighted to publish the first case study into the use of Analyse-it.
Marco Balerna Ph.D., a Clinical Chemist at the in Switzerland, used Analyse-it when replacing the clinical chemistry and immunological analysers in EOC’s laboratories.
Since the EOC provides clinical chemistry services to five large hospitals and three small clinics in the region, it was essential the transition to the new analysers went smoothly. Marco used Analyse-it to ensure the analyser’s performance met the manufacturer’s claims, to ensure the reporting of patient results was not affected, and to comply with the regulations of the EOC’s accreditation.
We've been developing intuitive high-quality statistical software at an affordable price, backed up by fast friendly customer service for over 25 years...
Office hours: 9am-5pm GMT Mon-Fri
It's Tuesday 5:02 PM and the office is closed - e-mail us and we'll get back to you as soon as possible.